It was back on the old Typed version of this blog that I last wrote about why I liked to write. It was shortly after Macgasm had folded, but before I wrote for Make Use Of. The seven months I have been without a professional home for my writing. My posts here have varied in their frequency, and there’s still a scant . . .
Morning, Computer - I think that in the next few years you're going to see this becoming a trend. Pulling back from the firehose isn't a bad thing, but Ellis stumbles on something even more useful here. The idea that we curate our own content means that you have to actually curate it. Twitter and Facebook became terrible because the . . .
The Verge - In what shouldn't surprise anyone, it turns out that the Foxconn deal was a little less lucrative than pitched in the press conference. The deal has already been altered now that the political capital was delivered, and it turns out that likely Wisconsin is going to join several other states in giving Foxconn a donation for . . .
STH - A thorough analysis of how the Bloomberg story about hacked motherboards is technically implausible if not impossible. It appears that in some cases the story conflates previously known hardware vulnerabilities like Spectre/Meltdown and exploiting BMC with a custom chip for spying, and in others, they are explicitly playing into fears . . .
Nuerologica - It's little more than the return of patent medicine, complete with unaccountable ingredients listing, and worst than that it can kill. This poor guy survived the massive overdosing on Green Tea, but his health isn't likely to be the same. Regulations might not always protect you, but the supplement industry repeatedly . . .